Skip to search formSkip to main contentSkip to account menu

Hepatitis B Vaccines

Known as: Hepatitis B Vaccines [Chemical/Ingredient], Vaccines, Hepatitis B, Hepatitis B vaccine 
Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
BACKGROUND China reduced hepatitis B virus (HBV) infection by 90% among children under 5 years old with safe and effective… 
Highly Cited
2011
Highly Cited
2011
CONTEXT Alternative schedules more immunogenic than the standard hepatitis B vaccine regimen are needed in patients with human… 
Review
2011
Review
2011
The number of approaches to recombinant protein production in plants is greater than ever before. Development of these new and… 
Highly Cited
2003
Highly Cited
2003
Patients who undergo transplantation for hepatitis B virus (HBV)‐related diseases are treated indefinitely with hepatitis B… 
Review
2002
Review
2002
About 170 million Chinese are infected chronically with HBV and 10% suffer from chronic hepatitis. Around half a million Chinese… 
Review
1989
Review
1989
Hepatitis B is a disease that affects people throughout the world, and over 200 million are persistent carriers of the hepatitis… 
Highly Cited
1984
Highly Cited
1984
We evaluated the immunogenicity and efficacy of hepatitis B vaccine (Heptavax-B) in a randomized, double-blind, placebo… 
Highly Cited
1984
Highly Cited
1984
In a double-blind trial, we randomly assigned 1330 high-risk health care personnel to receive three 20-micrograms doses of…